Monoclonal antibodies recognizing CD5, CD10 and CD23 in formalin-fixed, paraffin-embedded tissue: Production and assessment of their value in the diagnosis of small B-cell lymphoma

Histopathology

Volumn 36, Issue 2, 2000, Pages 145-150

  Watson, P ^a   Wood, K M ^a   Lodge, A ^a   McIntosh, G G ^a   Milton, I ^a   Piggott, N H ^a   Proctor, S J ^a   Taylor, P R ^a   Smith, S ^a   Jack, F ^a   Bell, H ^a   Steward, M ^a   Anderson, J J ^a   Horne, C H W ^a   Angus, B ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

CD10; CD23; CD5; Follicle centre cell; Immunohistochemistry; Lymphocytic; Lymphoma; Lymphoplasmacytoid; Mantle cell; Marginal zone; Monoclonal antibody

Indexed keywords

CD23 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; FORMALDEHYDE; MONOCLONAL ANTIBODY; PARAFFIN; RECOMBINANT PROTEIN;

ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; HYBRIDOMA; IMMUNOHISTOCHEMISTRY; LYMPHOCYTOMA; MANTLE CELL LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD5; BLOTTING, WESTERN; CYCLIN D1; FIXATIVES; FORMALDEHYDE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, MANTLE-CELL; LYMPHOMA, SMALL LYMPHOCYTIC; MICE; NEPRILYSIN; PARAFFIN EMBEDDING; RECEPTORS, IGE; TISSUE FIXATION;

EID: 0034003039     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2000.00813.x     Document Type: Article

References (26)

1. 1. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84; 1361-1392.
2. 2. Dorfman DM, Pinkus GS. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23. Mod. Pathol. 1994; 7; 326-331.
3. 3. Kumar S, Green GA, Teruya-Feldstein J, Raffeld M, Jaffe ES. Use of CD23 (BU38) on paraffin sections in the diagnosis of small lymphocytic and mantle cell lymphoma. Mod. Pathol. 1996; 9; 925-929.
4. 4. Stein H, Lennert K, Fellar AC. Immunohistological analysis of human lymphoma: correlation of histological and immunological categories. Adv. Cancer Res. 1984; 42; 67-147.
5. 5. Zukerberg LR, Medeiros LJ, Ferry JA, Harris NL. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am. J. Clin. Pathol. 1993; 100; 373-385.
6. 6. Dunphy CH, Sheaton SE, Perkins SL. CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma. Mod. Pathol. 1997; 10; 818-822.
7. 7. Contos MJ, Kornstein MJ, Innes DJ, Ben-Ezra J. The utility of CD20 and CD43 in subclassification of low-grade B-cell lymphoma on paraffin sections. Mod. Pathol. 1992; 5; 631-633.
8. 8. Treasure J, Lane A, Jones DB, Wright DH. CD43 expression in B cell lymphoma. J. Clin. Pathol. 1992; 45; 1018-1022.
9. 9. Alkan S, Schnitzer B, Thompson JL, Moscinski LC. Cyclin D1 protein expression in mantle cell lymphoma. Ann. Oncol. 1995; 6; 567-570.
10. 10. de Boer CJ, Schuuring E, Dreef E et al. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 1995; 86; 2715-2723.
11. 11. Nakamura S, Yatabe Y, Kuroda H et al. Immunostaining of PRAD1/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma. Leukemia 1997; 11 (Suppl. 3); 536-537.
12. 12. Van de Velde H, von Hoegen I, Luo W, Parnes JR, Thielemans K. The B-cell surface protein CD72a/Lyb-4 is the ligand for CD5. Nature 1991; 351; 662-665.
13. 13. LeBien TW, McCormack RT. The common acute lymphoblastic leukemia antigen (CD10) - emancipation from a functional enigma. Blood 1989; 73; 625-635.
14. 14. Conrad DH. Fc epsilon RII/CD23: the low affinity receptor for IgE. Annu. Rev. Immunology 1990; 8; 623-645.
15. 15. Richards ML, Katz DH. Biology and chemistry of low affinity IgE receptor (Fc epsilon RII/CD23). Crit Rev. Immunol. 1991; 11; 65-86.
16. 16. McIntosh GG, Lodge AJ, Watson P et al. NCL-CD10-270: a new monoclonal antibody recognizing CD10 in paraffin-embedded tissue. Am. J. Pathol. 1999; 154; 77-82.
17. 17. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162; 156-159.
18. 18. Dorfman DA, Shahsafaei A. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections. Mod. Pathol. 1997; 10; 859-863.
19. 19. Kauffman O, Flath B, Spath-Schwalbe E, Possinger K, Dietel M. Immunohistochemical detection of CD5 with monoclonal antibody 4C7 on paraffin sections. Am. J. Clin. Pathol. 1997; 108; 669-673.
20. 20. Ballesteros E, Osborne BM, Matsushima AY. CD5+ low grade marginal zone B-cell lymphomas with localised presentation. Am. J. Surg. Pathol. 1998; 22; 201-207.
21. 21. Williams ME, Swerdlow SH, Rosenberg CL, Arnold A. Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia 1993; 7; 241-245.
22. 22. Dreger P, von Neuhoff N, Kuse R et al. Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphoma. Ann. Oncol. 1997; 8; 401-403.
23. 23. Freedman AS, Neuberg D, Gribben JG et al. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. J. Clin. Oncol. 1998; 16; 13-18.
24. 24. Haas R, Brittinger G, Meusers P et al. Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma. Leukemia 1996; 10; 1975-1979.
25. 25. Ketterer N, Salles G, Espinouse D et al. Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma. Ann. Oncol. 1993; 8; 701-704.
26. 26. Stewart DA, Vose JM, Weisenburger DD et al. The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Ann. Oncol. 1995; 6; 263-266.